News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Tanya Jindal: Biomarkers associated with response to EV monotherapy in patients with Advanced Urothelial Carcinoma
Tanya Jindal/X
Dec 26, 2024, 14:42

Tanya Jindal: Biomarkers associated with response to EV monotherapy in patients with Advanced Urothelial Carcinoma

Tanya Jindal, Physician Scientist at Interested in GU Oncology, shared a recent article on X:

“Check out our paper in European Urology Oncology (EUO) highlighting biomarkers associated with response to EV monotherapy in patients with advanced Urothelial Carcinoma.

TMB high associated with improved OS.

CDKN2A/B associated with decreased PFS.”

Title: Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data

Authors: Tanya Jindal, Cindy Jiang, Omar Alhalabi, Amanda Nizam, Charles Nguyen, Rafee Talukder, Dimitra Bakaloudi, Matthew Davidsohn, Dory Freeman, Michael Glover, Ali Raza Khaki, Sean Evans, Emily Lemke, Rohit Bose, Woogwang Sim, Cameron Pywell, Arnab Basu, Deepak Kilari, Pedro C. Barata, Mehmet A. Bilen, Yousef Zakharia, Matthew I. Milowsky, Sumit A. Shah, Joaquim Bellmunt, Petros Grivas, Hamid Emamekhoo, Nancy B. Davis, Shilpa Gupta, Christopher Hoimes, Matthew T. Campbell, Ajjai Alva and Vadim S. Koshkin

Tanya Jindal

For more updates, follow OncoDaily.

Amanda Nizam cancer Charles Nguyen Cindy Jiang Dimitra Bakaloudi EUO EV monotherapy Omar Alhalabi OncoDaily Oncology Rafee Talukder Tanya Jindal urothelial carcinoma Vadim S Koshkin
Special Coverage
Insight
Dec 26, 2024, 14:44
ESTRO25 Abstract Insights
Science
Dec 26, 2024, 14:42
Tanya Jindal: Biomarkers associated with response to EV monotherapy in patients with Advanced Urothelial Carcinoma
Insight
Dec 26, 2024, 14:37
Jayastu Senapati: Treated Secondary-AML, 673 patients, largest reported cohort
Insight
Dec 26, 2024, 14:36
Fox Chase Cancer Center’s Pilot Program Enhances Palliative Care Training for Hematology/Oncology Fellows
Insight
Dec 26, 2024, 14:33
The impact of the COVID-19 pandemic among children and adolescents with cancer and their families
Insight
Dec 26, 2024, 14:23
Study exploring the role of the lncRNA NEAT1 as an attractive therapeutic candidate in multiple myeloma
Insight
Dec 26, 2024, 14:21
Arndt Vogel: Radiofrequency Ablation vs Stereotactic Body Radiotherapy for Recurrent Small HCC
Blog
Dec 26, 2024, 14:13
David Planchard: Welcoming Mohyeldin Abdelhalim to attend thoracic consultations at the Gustave Roussy Institute
Insight
Dec 26, 2024, 14:10
Adham Ahmed: Quick way to read major cardio thoracic surgery trial results by TSMA
Science
Dec 26, 2024, 14:07
Iannis Aifantis: Deep dive on 3D nuclear and chromosomal landscapes in acute leukemia
Blog
Dec 26, 2024, 14:01
Antonio M. Grimaldi: The visit of the Three Wise Men of the Living Nativity Scene of Pietrelcina
Insight
Dec 26, 2024, 13:53
Darío Solís-Sayago: Unleashing the Full Potential of Tissue-Resident NK Cells Through TGF-β1